| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.14 | 0.1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.1 |